Background: Pancytopenia refers to a reduction in all the three cellular elements of blood. The aim of this study was to identify the various causes of pancytopenia in patients attending to Manipal teaching hospital in Pokhara.
INTRODUCTION
Pancytopenia is a reduction in all the three cellular elements of blood; exists in adult when the hemoglobin level is less than 10g/dL, total leukocyte count is less than 4x10 9 /L, and platelet count is less than 150x10 9 /L. 1 Pancytopenia can be due to decrease in hemopoietic cell production, ineffective haemopoiesis or peripheral destruction of the cells. The haemopoietic cell production can be influenced in the bone marrow by infections, toxins, malignant cell infiltration leading to hypocellular marrow. Ineffective hematopoiesis and dysplasia, maturation arrest of all the cell lines and peripheral sequestration of blood cells or peripheral destruction of all blood cells lineage can also be the cause of pancytopenia. [2] [3] [4] [5] Pancytopenia is a common hematological problem with an extensive differential diagnosis, and the optimal diagnostic approach to pancytopenia remains undefined. 6-8 Pancytopenia is not a disease but a triad of findings that may result from a number of disease processes. These disorders may affect bone marrow either primarily or secondarily, resulting in the manifestation of pancytopenia. 9 The aim of this study was to identify the various causes of pancytopenia in patients attending to Manipal teaching hospital in Pokhara.
MATERIALS AND METHODS
Patients admitted to the hospital with pancytopenia through outpatient department or the emergency were enrolled in this study. Detail history and clinical examination were carried out. Various clinical and hematological parameters were noted including age at presentation and drug history. All the patients were subjected to examination of their complete blood count, peripheral blood smear, bone marrow aspiration and bone 210 marrow biopsy. Peripheral blood smears were stained with Leishman stain. For reticulocyte count brilliant cresyl blue stain was used.
Bone marrow (BM) aspiration was performed from posterior superior iliac spine under aseptic condition. Slides were stained with routine Leishman stain and examined. Other special stains like Myeloperoxidase, Periodic acid and Schiff reagent were performed where necessary. Data were analyzed using SPSS 11.0 version.
RESULTS
Out of 54 cases 39 were males and 15 were females with male: female ratio of 2.6:1. The mean age was 40 years with a range of 5-82 years. The findings of bone marrow study are given in Table 1 . Hypoplastic bone marrow ( fig.1 ) was the most common finding (n=16, 29.6%). Among Hematological malignancies acute myeloid leukemia (AML) was the most common entity ( fig.2 ). Hematological malignancies are summarized in Table 2 .
The mean ages of ALL and AML were 14 and 37 years respectively. All cases of ALL occurred predominantly in children, the eldest being 17 years. Erythroid hyperplasia associated with pancytopenia was seen in younger patients (m= 26.17 years), where as the mean age of hypoplastic marrow, megaloblastic anemia and hematological malignancies were 48.25 years, 31.9 years and 47.38 respectively.
Anemia was the predominant presenting clinical feature (73.9%). The 2 nd most common clinical feature was fever (26.1%). Other presenting features were splenomegaly (13.1%), lymphadenopathy (3.7%), jaundice and bone tenderness (1.9% each). Leukopenia and thrombocytopenia were frequently associated with leukemias compare to other non-malignant hematological conditions.
DISCUSSION
The mechanism by which pancytopenia develops appears to be either associated with decrease in haematopoietic cell production as a result of destruction of the marrow tissue by toxins, replacement by abnormal or malignant tissue, or perhaps suppression of normal growth and differentiation.
In some patients the marrow may be normocellular or even hypercellular. The present study comprised of 54 patients with pancytopenia, which included 39 males and 15 females with male:female ratio of 2.6:1. The mean age was 40 years with a range of 5-82 years. Adults: Children ratio was 6.7:1. Different male to female ratio and age range were observed in different studies. [10] [11] [12] The most significant BM finding was hypoplastic bone marrow in about 29.6% of the cases of pancytopenia. Hematological malignancy (29.6%) was the next frequently occurring cause, followed by megaloblastic anemia (24.1%) and erythroid hyperplasia (11.11%). The common causes of pancytopenia of this study are compared with the findings in other studies in Table 3 .
In this study pallor was present in 73.9% of cases, followed by fever in 26.1%, splenomegaly in 13.1% and 3.8% with bleeding abnormalities. Similar findings were observed in other studies. 10, 18 Mussarrat N et al 9 showed 47.7% of cases with fever and 33.7% with bleeding. In the present study splenomegaly was seen in 13.1% of the cases with pancytopenia. The frequency of splenomegaly was comparable to various studies.
9,10
Pancytopenia can be seen in 30% of acute leukemia at the time of presentation. 10 In our study, 27.78% of patients presented with malignant etiology with pancytopenia and was the next most common cause of pancytopenia. AML was the most common malignancy diagnosed in 12.96% of the total cases whereas Jha A et al found AML to be 19.59% of total cases.
10 AML (12.96%) in the present study included more cases than erythroid hyperplasia (11.11%) and normal bone marrow (7.41%). Savage et al 7 in Zimbabwe and Varma N et al 15 also described AML as the third most common cause of pancytopenia.
In this study ALL comprised of 13.3% case; of the total hematological malignancy. The age range was from 11-17 years with a mean of 14 years, showing involvement of children only. In other study, 28.21% of the hematological malignancies comprised of ALL with mean age of 13 years ranging from 2-33 years. 10 In the general populations MDS account for 5 per 1, 00,000 people. However, among individuals older than 70 years, the incidence increased from 22-45 per 1,00,000 people and increasing further with the age. 19 In this study, 7.4% of the total cases were diagnosed as MDS. The age group ranges from 30-79 years.
In the present study, 24.1% (n=13) cases with pancytopenia were diagnosed as megaloblastic anemia, and was the third most common cause of pancytopenia while in other similar studies it varied from 0.8% to 80%. 9 Khanduri U et al 20 found the incidence of megaloblastic anemia to be 64%, and as the most common cause of pancytopenia. The high prevalence of nutritional anemia in India has been cited for increase in frequency of megaloblastic anemia. 10 Chronically ill patients have been reported to have folic acid deficiency resulting in florid megaloblastic changes in the marrow precipitating into pancytopenia. 17 In this study apart from pallor, splenomegaly (23%), fever (7.7%) and bony tenderness (7.7%) were other clinical manifestation in the patients with megaloblastic anemia. Various studies have shown myriads of clinical features associated with megaloblastic anemia. Shazia M et al 18 in their study have described the presenting features of megaloblastic anemia as pallor with varying degree of skin and mucosal bleedings. Bleeding manifestations was not seen in the present study. Osaman I et al 8 have shown fever (56.4%), bleeding (38.8%), diarrhoea (38.5%), anovexia (35.9%) in patients with pancytopenia due to megaloblastic anemia. Khanduri et al 20 mentioned predominant symptoms as fatigue, anorexia and gastritis, low grade fever, dyspnea and mild jaundice in megaloblastic anemia. Osaman I et al 8 in their study found 15.4% of megaloblastic anemia with splenomegaly.
CONCLUSION
The commonest cause of pancytopenia in our study was hypoplastic bone marrow followed by hematological malignancies and megaloblastic anemia. There are varying trends in its clinical pattern, treatment modalities, and outcome depending on the different causes of pancytopenia which should be kept in mind while managing it. 
